{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:44:02Z","timestamp":1791341042613,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T00:00:00Z","timestamp":1224460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2334-8-141","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T06:14:03Z","timestamp":1224569643000},"source":"Crossref","is-referenced-by-count":48,"title":["An A2Aadenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models"],"prefix":"10.1186","volume":"8","author":[{"given":"Christopher C","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward N","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Obrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Michael","family":"Scheld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,20]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-54. 10.1056\/NEJMoa022139.","journal-title":"N Engl J Med"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","volume":"25","author":"F Zeni","year":"1997","unstructured":"Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997, 25: 1095-100. 10.1097\/00003246-199707000-00001.","journal-title":"Crit Care Med"},{"key":"732_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056\/NEJM200103083441001.","journal-title":"N Engl J Med"},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1286-4579(03)00068-6","volume":"5","author":"M Thiel","year":"2003","unstructured":"Thiel M, Caldwell CC, Sitkovsky MV: The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect. 2003, 5: 515-26. 10.1016\/S1286-4579(03)00068-6.","journal-title":"Microbes Infect"},{"key":"732_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5603-9","volume-title":"Cardiovascular Biology of Purines","author":"G DJ Burnstock","year":"1998","unstructured":"DJ Burnstock G, Liang BT, Liden J: Cardiovascular Biology of Purines. 1998, London: Kluwer Academic Publishers, 1","edition":"1"},{"key":"732_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/sj.bjp.0703893","volume":"132","author":"GW Sullivan","year":"2001","unstructured":"Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J: Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol. 2001, 132: 1017-26. 10.1038\/sj.bjp.0703893.","journal-title":"Br J Pharmacol"},{"key":"732_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta A, Sitkovsky M: Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001, 414: 916-20. 10.1038\/414916a.","journal-title":"Nature"},{"key":"732_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/01.shk0000225856.32260.0d","volume":"26","author":"T Schreiber","year":"2006","unstructured":"Schreiber T, Swanson PE, Chang KC, Davis CC, Dunne WM, Karl IE, Reinhart K, Hotchkiss RS: Both gram-negative and gram-positive experimental pneumonia induce profound lymphocyte but not respiratory epithelial cell apoptosis. Shock. 2006, 26: 271-6. 10.1097\/01.shk0000225856.32260.0d.","journal-title":"Shock"},{"key":"732_CR9","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.1073\/pnas.93.22.12467","volume":"93","author":"JD Gorham","year":"1996","unstructured":"Gorham JD, Guler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM: Genetic mapping of a murine locus controlling development of T helper 1\/T helper 2 type responses. Proc Natl Acad Sci USA. 1996, 93: 12467-72. 10.1073\/pnas.93.22.12467.","journal-title":"Proc Natl Acad Sci USA"},{"key":"732_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.7326\/0003-4819-125-8-199610150-00009","volume":"125","author":"R Bone","year":"1996","unstructured":"Bone R: Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Annals of Internal Medicine. 1996, 125: 680-687.","journal-title":"Annals of Internal Medicine"},{"key":"732_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4049\/jimmunol.174.2.1073","volume":"174","author":"CM Lappas","year":"2005","unstructured":"Lappas CM, Rieger JM, Linden J: A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol. 2005, 174: 1073-80.","journal-title":"J Immunol"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1086\/386311","volume":"189","author":"GW Sullivan","year":"2004","unstructured":"Sullivan GW, Fang G, Linden J, Scheld WM: A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis. 2004, 189: 1897-904. 10.1086\/386311.","journal-title":"J Infect Dis"},{"key":"732_CR13","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/IAI.55.7.1622-1625.1987","volume":"55","author":"F Bauss","year":"1987","unstructured":"Bauss F, Droge W, Mannel DN: Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun. 1987, 55: 1622-5.","journal-title":"Infect Immun"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1056\/NEJM199006073222302","volume":"322","author":"T van der Poll","year":"1990","unstructured":"Poll van der T, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med. 1990, 322: 1622-7.","journal-title":"N Engl J Med"},{"key":"732_CR15","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1084\/jem.177.5.1277","volume":"177","author":"F Mackay","year":"1993","unstructured":"Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W: Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med. 1993, 177: 1277-86. 10.1084\/jem.177.5.1277.","journal-title":"J Exp Med"},{"key":"732_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1086\/315084","volume":"180","author":"GW Sullivan","year":"1999","unstructured":"Sullivan GW, Linden J, Buster BL, Scheld WM: Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis. 1999, 180: 1550-60. 10.1086\/315084.","journal-title":"J Infect Dis"},{"key":"732_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/jars.2001.21492","volume":"17","author":"CJ Hogan","year":"2001","unstructured":"Hogan CJ, Fang GD, Scheld WM, Linden J, Diduch DR: Inhibiting the inflammatory response in joint sepsis. Arthroscopy. 2001, 17: 311-315.","journal-title":"Arthroscopy"},{"key":"732_CR18","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.4049\/jimmunol.148.9.2764","volume":"148","author":"Fahey TJ 3rd","year":"1992","unstructured":"TJ Fahey, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, Cerami A, Sherry B: Macrophage inflammatory protein 1 modulates macrophage function. J Immunol. 1992, 148: 2764-9.","journal-title":"J Immunol"},{"key":"732_CR19","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.4049\/jimmunol.144.8.3034","volume":"144","author":"A Sica","year":"1990","unstructured":"Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae CO, Matsushima K: Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol. 1990, 144: 3034-8.","journal-title":"J Immunol"},{"key":"732_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-2567.1999.00832.x","volume":"97","author":"AP Mountford","year":"1999","unstructured":"Mountford AP, Coulson PS, Cheever AW, Sher A, Wilson RA, Wynn TA: Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses. Immunology. 1999, 97: 588-94. 10.1046\/j.1365-2567.1999.00832.x.","journal-title":"Immunology"},{"key":"732_CR21","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP: IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol. 1998, 160: 3513-21.","journal-title":"J Immunol"},{"key":"732_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1084\/jem.167.2.570","volume":"167","author":"SD Wolpe","year":"1988","unstructured":"Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A: Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med. 1988, 167: 570-81. 10.1084\/jem.167.2.570.","journal-title":"J Exp Med"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/08830189809043008","volume":"16","author":"F Fossiez","year":"1998","unstructured":"Fossiez F, Banchereau J, Murray R, van Kooten C, Garrone P, Lebecque S: Interleukin-17. Int Rev Immunol. 1998, 16: 541-51. 10.3109\/08830189809043008.","journal-title":"Int Rev Immunol"},{"key":"732_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1172\/JCI6224","volume":"103","author":"J Wang","year":"1999","unstructured":"Wang J, Wakeham J, Harkness R, Xing Z: Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest. 1999, 103: 1023-9. 10.1172\/JCI6224.","journal-title":"J Clin Invest"},{"key":"732_CR25","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.4049\/jimmunol.155.10.4790","volume":"155","author":"GB Huffnagle","year":"1995","unstructured":"Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA, Burdick MD, Kunkel SL, Toews GB: The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol. 1995, 155: 4790-7.","journal-title":"J Immunol"},{"key":"732_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1086\/314559","volume":"179","author":"NP O'Grady","year":"1999","unstructured":"O'Grady NP, Tropea M, HL Preas, Reda D, Vandivier RW, Banks SM, Suffredini AF: Detection of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta during experimental endotoxemia and human sepsis. J Infect Dis. 1999, 179: 136-41. 10.1086\/314559.","journal-title":"J Infect Dis"},{"key":"732_CR27","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1128\/IAI.60.7.2835-2842.1992","volume":"60","author":"CE Hack","year":"1992","unstructured":"Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun. 1992, 60: 2835-42.","journal-title":"Infect Immun"},{"key":"732_CR28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4049\/jimmunol.155.3.1515","volume":"155","author":"TJ Standiford","year":"1995","unstructured":"Standiford TJ, Kunkel SL, Lukacs NW, Greenberger MJ, Danforth JM, Kunkel RG, Strieter RM: Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol. 1995, 155: 1515-24.","journal-title":"J Immunol"},{"key":"732_CR29","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.4049\/jimmunol.154.9.4793","volume":"154","author":"TP Shanley","year":"1995","unstructured":"Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA: Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J Immunol. 1995, 154: 4793-802.","journal-title":"J Immunol"},{"key":"732_CR30","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.4049\/jimmunol.170.4.1958","volume":"170","author":"DR Chung","year":"2003","unstructured":"Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, Tzianabos AO: CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003, 170: 1958-63.","journal-title":"J Immunol"},{"key":"732_CR31","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1128\/IAI.69.12.7172-7276.2001","volume":"69","author":"B Echtenacher","year":"2001","unstructured":"Echtenacher B, Freudenberg MA, Jack RS, Mannel DN: Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun. 2001, 69: 7271-6. 10.1128\/IAI.69.12.7172-7276.2001.","journal-title":"Infect Immun"},{"key":"732_CR32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/IAI.63.4.1165-1172.1995","volume":"63","author":"A Nakane","year":"1995","unstructured":"Nakane A, Okamoto M, Asano M, Kohanawa M, Minagawa T: Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun. 1995, 63: 1165-72.","journal-title":"Infect Immun"},{"key":"732_CR33","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"R de Waal Malefyt","year":"1991","unstructured":"de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991, 174: 1209-20. 10.1084\/jem.174.5.1209.","journal-title":"J Exp Med"},{"key":"732_CR34","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","volume":"178","author":"A D'Andrea","year":"1993","unstructured":"D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells. J Exp Med. 1993, 178: 1041-8. 10.1084\/jem.178.3.1041.","journal-title":"J Exp Med"},{"key":"732_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1084\/jem.177.2.547","volume":"177","author":"C Gerard","year":"1993","unstructured":"Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993, 177: 547-50. 10.1084\/jem.177.2.547.","journal-title":"J Exp Med"},{"key":"732_CR36","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.177.4.1205","volume":"177","author":"M Howard","year":"1993","unstructured":"Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 1993, 177: 1205-8. 10.1084\/jem.177.4.1205.","journal-title":"J Exp Med"},{"key":"732_CR37","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.4049\/jimmunol.166.10.6323","volume":"166","author":"ME Sewnath","year":"2001","unstructured":"Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ, Poll van Der T: IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol. 2001, 166: 6323-31.","journal-title":"J Immunol"},{"key":"732_CR38","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1128\/IAI.70.8.4441-4446.2002","volume":"70","author":"SQ Latifi","year":"2002","unstructured":"Latifi SQ, O'Riordan MA, Levine AD: Interleukin-10 controls the onset of irreversible septic shock. Infect Immun. 2002, 70: 4441-6. 10.1128\/IAI.70.8.4441-4446.2002.","journal-title":"Infect Immun"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-8-141\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:46:50Z","timestamp":1684601210000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-8-141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-8-141","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,20]]},"article-number":"141"}}